P659: BUPARLISIB A PROMISING THERAPEUTIC APPROACH IN CHRONIC MYELOID LEUKEMIA RESISTANT TO IMATINIB
Raquel Alves,
Inês Silva,
Maria Inês Costa,
Beatriz Lapa,
Joana Jorge,
Ana Cristina Gonçalves,
Ana Bela Sarmento-Ribeiro
Affiliations
Raquel Alves
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Inês Silva
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Maria Inês Costa
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Beatriz Lapa
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Joana Jorge
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Ana Cristina Gonçalves
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
Ana Bela Sarmento-Ribeiro
1 Faculty of Medicine (FMUC), University of Coimbra, Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology and Oncology, Coimbra, Portugal
